Oramed Pharmaceuticals (NASDAQ: ORMP)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Oramed Pharmaceuticals (NASDAQ: ORMP) through any online brokerage.
The latest price target for Oramed Pharmaceuticals (NASDAQ: ORMP) was reported by Aegis Capital on Monday, May 16, 2022. The analyst firm set a price target for 30.00 expecting ORMP to rise to within 12 months (a possible 552.17% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $4.6 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Oramed Pharmaceuticals.
Oramed Pharmaceuticals’s Q3 earnings are confirmed for Monday, July 18, 2022.
There is no upcoming split for Oramed Pharmaceuticals.
Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.